drugset / Trial / NCT04222842
CM082 in Patients With Myopic Choroidal Neovascularization (CNV)
NaSequentialOpen-labelTreatment
Summary
This is a Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Intermittent Oral Dosing of CM082 tablets in Chinese Patients With mCNV.
Timeline
- Start
- 2019-12-18
- Primary completion
- 2021-12-30
- Completion
- 2021-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CM082 | Unknown | 25 mg | Oral |
| Subject | CM082 | Unknown | 50 mg | Oral |